ArticleBioMed research international2021

Tofacitinib Ameliorates Lipopolysaccharide-Induced Acute Kidney Injury by Blocking the JAK-STAT1/STAT3 Signaling Pathway.

Yang Yun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.